Imaging & Diagnostics

Can Medical AI Identify You From De-Identified Data?
Imaging & Diagnostics Can Medical AI Identify You From De-Identified Data?

The assumption that removing a name and social security number from a medical record ensures complete anonymity is rapidly becoming a relic of the past as sophisticated artificial intelligence systems evolve. While healthcare providers have long relied on de-identification protocols to share data

MIT Develops Portable Ultrasound for Breast Cancer Detection
Imaging & Diagnostics MIT Develops Portable Ultrasound for Breast Cancer Detection

Early detection remains the most critical factor in surviving a breast cancer diagnosis, yet current medical protocols often leave patients vulnerable during the long stretches between annual hospital visits where aggressive tumors can emerge undetected. Researchers at MIT have successfully

CMS Proposes Major 340B and Site-Neutral Payment Reforms
Imaging & Diagnostics CMS Proposes Major 340B and Site-Neutral Payment Reforms

The federal government has initiated an unprecedented transformation of the Medicare payment structure to address the rising costs of outpatient care and pharmaceutical expenses. The Centers for Medicare & Medicaid Services has recently unveiled a comprehensive regulatory framework for the 2027

Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?
Imaging & Diagnostics Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?

For decades, the standard medical protocol for identifying endometriosis has required patients to undergo invasive laparoscopic surgery just to confirm a condition that affects nearly ten percent of the global female population during their reproductive years. This diagnostic bottleneck has

How Will MRI Contrast Agents Transform Diagnostics by 2030?
Imaging & Diagnostics How Will MRI Contrast Agents Transform Diagnostics by 2030?

The landscape of precision medicine is undergoing a profound transformation as advanced imaging technologies provide increasingly clear windows into the human body's complex biological systems. As the healthcare industry moves toward 2030, the market for MRI contrast agents is projected to rise

New Anti-Lipid Biomarkers Advance Lyme Disease Diagnostics
Imaging & Diagnostics New Anti-Lipid Biomarkers Advance Lyme Disease Diagnostics

The diagnostic landscape for Lyme disease has long been marred by a frustrating lack of precision, leaving thousands of patients caught between debilitating symptoms and inconclusive laboratory results. For decades, medical professionals have relied on testing methods that often fail to catch the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later